This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.

 
Web www.patentalert.com

< Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3

> Diagnosis and treatment of infectious diseases through indel-differentiated proteins

> Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
~ 00511